Veru Inc. sold its FC2 Female Condom business for $18 million, resulting in a significant reduction in workforce. The company aims to focus on its biopharmaceutical development, with promising drug pipelines like enobosarm and sabizabulin.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing